Albireo Pharma, Inc.
ALBO · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $447,657 | $599,522 | $316,174 | $287,075 |
| - Cash | $248,107 | $251,272 | $131,843 | $163,885 |
| + Debt | $10,004 | $9,621 | $0 | $0 |
| Enterprise Value | $209,554 | $357,871 | $184,331 | $123,190 |
| Revenue | $40,579 | $8,308 | $9,636 | $12,740 |
| % Growth | 388.4% | -13.8% | -24.4% | – |
| Gross Profit | $39,223 | $8,308 | $7,426 | $12,740 |
| % Margin | 96.7% | 100% | 77.1% | 100% |
| EBITDA | -$19,824 | -$96,079 | -$57,294 | -$37,845 |
| % Margin | -48.9% | -1,156.5% | -594.6% | -297.1% |
| Net Income | -$151,349 | -$118,995 | -$71,704 | -$46,111 |
| % Margin | -373% | -1,432.3% | -744.1% | -361.9% |
| EPS Diluted | -7.87 | -7.45 | -5.77 | -3.94 |
| % Growth | -5.6% | -29.1% | -46.4% | – |
| Operating Cash Flow | -$107,559 | -$101,029 | -$52,919 | -$26,802 |
| Capital Expenditures | -$465 | -$78 | -$540 | -$61 |
| Free Cash Flow | -$108,024 | -$101,107 | -$53,459 | -$26,863 |